Evidence map›Paper›PMID 39320315›Full record

ArticleNanomedicine (London, England)2024

Mineralo-organic particles inhibit influenza A virus infection by targeting viral hemagglutinin activity.

Huan-Jung Chiang, Hsin-Hsin Peng, Kuo-Feng Weng, Kuei-Ching Hsiung, Chieh-Yu Liang, Shun-Li Kuo, David M Ojcius, John Ding-E Young, Shin-Ru Shih

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huan-Jung ChiangResearch Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.ORCID 0000-0002-9785-5667
Hsin-Hsin PengCenter for Molecular & Clinical Immunology, Chang Gung University, Taoyuan, 33302, Taiwan.ORCID 0000-0002-7049-4021
Kuo-Feng WengResearch Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.
Kuei-Ching HsiungResearch Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.ORCID 0000-0002-2107-6368
Chieh-Yu LiangResearch Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.
Shun-Li KuoDivision of Chinese Medicine Obstetrics & Gynecology, Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, 33305, Taiwan.
David M OjciusCenter for Molecular & Clinical Immunology, Chang Gung University, Taoyuan, 33302, Taiwan.
John Ding-E YoungChang Gung Biotechnology Corporation, Taipei, 10508, Taiwan.
Shin-Ru ShihResearch Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.ORCID 0000-0003-4874-401X

Funding

Chang Gung Memorial Hospital, LinkouMinistry of Education of Taiwan
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hemagglutinin Glycoproteins, Influenza VirusInfluenza A virusInfluenza, HumanAnimalsAntiviral AgentsDogsHumansMadin Darby Canine Kidney CellsVirionAntiviral AgentsHemagglutinin Glycoproteins, Influenza Virusfetuin-Ahemagglutinationhemagglutinininfectious diseasesinfluenza A virusmineralo-organic particlesmineral particles

Identifiers

PMID39320315
PMCPMC11492690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.